section 31.2 
Pituitary Gland (Hypophysis)
743
S>
<
s>
<
E>
<
Pro-opiomelanocortin (PMOC)
----------- f
E?
<
2 3 0 +
Human N-terminal (hNT)
---------------- >—
r
7 6
%-MSH
2 7
ACTH
— f-----
3 9
<
ß-Lipotropin ( ß-LPH)
91
I 
ß-Endorphinl *
5 8 
31
Intermediate lobe of subhuman species
a-MSH
CLIP
ß-MSH |
1 3
22
22
FIGURE 31-7
Posttranslational processing of pituitary pro-opiomelanocortin (pmoc). * , Released into blood.
and/or brain may be capable of forming 
a-
and /1-MSH 
from POMC, since these peptides appear to exert central 
effects.
Inherited defects in POMC production result in defi-
ciency or a complete lack of secretion of ACTH, MSH (a -, 
fi-, y-),
and /1-endorphin. These patients exhibit adrenal 
insufficiency, red hair pigmentation, and early-onset obe-
sity that has been related to deficiency of a-MSH pro-
duction. Animal studies have shown that a-MSH regu-
lates food intake by activation of melanocortin receptor-4 
(Chapters 5 and 22). In mioe, a 
POMC
gene defect also 
leads to adrenal deficiency, altered pigmentation, and obe-
sity with loss of a significant portion of the patient’s ex-
cess weight when he or she is treated with a stable a-MSH 
preparation. Other genetic causes of obesity include de-
fects in genes encoding prohormone convertase
- 1
(i.e., in-
ability to convert POMC to various peptides), leptin, and 
leptin receptor (Chapters 5 and 22).
ACTH
(Table 31 -
6
) is a polypeptide of 39 residues, the 
first 24 of which are required for corticotropic activity and 
do not vary among species. ACTH] 
2 4
has been synthe-
sized and is used for diagnostic purposes. Because it con-
tains the MSH sequence in residues 6-9 (His-Phe-Arg- 
Trp), ACTH has intrinsic melanocyte-stimulating activity; 
it can thus cause skin darkening if present in high con-
centrations. In normal adults, the pituitary contains about
0.25 mg of ACTH, and the basal level of ACTH in blood 
is about 50 pg/mL.
ACTH acts mainly on the cells of the zona fasciculata 
of the adrenal cortex to stimulate the synthesis and release 
of cortisol (Chapter 32). It also stimulates the secretion of 
adrenal androgens from the zona reticularis. Binding of 
ACTH to receptors activates formation of cAMP, which 
mediates cortisol formation and secretion and protein syn-
thesis. Deficiency of ACTH leads to reduction in size and 
activity of adrenocortical cells in the inner two zones.
ACTH secretion is regulated so as to ensure constant, 
adequate levels of cortisol in blood. Corticotrophs in 
the pituitary are under tonic stimulation by CRH and 
are modulated by the negative feedback effect of blood 
cortisol, which inhibits POMC synthesis by repression 
of the 
POMC
gene. Although cortisol also exerts an 
effect on the hypothalamus and related areas in the 
brain (limbic system, reticular formation), this activity 
may involve the regulation of emotion and behavior and 
not of CRH release. The regulation of the ACTH and 
cortisol is illustrated in Figure 31-8. Secretion of POMC 
in the intermediate lobe is not regulated by CRH and 
glucocorticoids, since the intermediate lobe is poorly 
vascularized and contains no glucocorticoid receptors. 
However, the intermediate lobe is rich in dopaminergic 
fibers, so that dopamine agonists (ergocryptine) decrease,
 
    
